Level Zero Health announced that it raised $6.9 million in a pre-seed funding round to support its remote, continuous ...

Wearable sweat biosensors enable the non-invasive, real-time monitoring of hormones. Here, we highlight the development and commercialization of a wearable technology that can measure hormone ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Continuous glucose monitoring (CGM) is wearable technology used to monitor glucose levels at all times. A sensor is placed beneath the arm's or belly's skin and reads interstitial glucose, which is ...

Multiphase Reactors and Intensification Group Bernal Institute, University of Limerick, Limerick V94T9PX, Ireland ...

The trial, which involved 30 diabetic participants, primarily those with Type 1 diabetes, assessed the performance of the redesigned CGM sensor over a 15-day period. The findings indicate superior ...

The first 24 hours of CGM wear have been a persistent weak spot across the industry, with sensor accuracy often fluctuating due to the body’s natural response to insertion. These advancements promise ...

offering the potential for direct blood glucose measurement without the limitations often seen with traditional continuous glucose monitors that measure glucose levels in interstitial fluid. "We are ...

RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...